2 most recent filings and news items mentioning CAPR. Updated every 60 seconds.
RegulatoryJul 29, 2026Positive
Capricor Therapeutics reported positive Phase 3 HOPE-3 trial data for Deramiocel, demonstrating efficacy and potentially accelerating the regulatory review process for its first FDA approval.
View filing at SEC.gov →
OptionsJul 9, 2026Neutral
9 Health Care Stocks With Whale Alerts In Today’s Session
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.